Kevin C. Tang
2016
In 2016, Kevin C. Tang earned a total compensation of $1 as Chairman and Chief Executive Officer at Odonate Therapeutics.
Compensation breakdown
| Salary | $1 |
|---|---|
| Total | $1 |
Tang received $1 in salary, accounting for 100% of the total pay in 2016.
Rankings
In 2016, Kevin C. Tang's compensation ranked 14,075th out of 14,075 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,075 out of 14,075 | 0th |
Division Manufacturing | 5,489 out of 5,489 | 0th |
Major group Chemicals And Allied Products | 1,895 out of 1,895 | 0th |
Industry group Drugs | 1,538 out of 1,538 | 0th |
Industry Pharmaceutical Preparations | 1,176 out of 1,176 | 0th |
Source: SEC filing on June 1, 2018.
News
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2020 pay falls 31% to $1.4M
June 1, 2021
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2019 pay jumps 37% to $2M
May 15, 2020
Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2018 pay jumps 465% to $1.4M
June 24, 2019